Bio Green Med Solution, Inc. (BGMS) fair value: what the stock is really worth
As of Oct 12, 2026: fair value of Bio Green Med Solution, Inc. $0.63, price $0.99, upside -36.5%, quality 46 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range $0.6000 – $10,462 · fair‑value band $0.4165 – $0.7905 · the $0.9900 price screens above the $0.6290 fair value. Dashed = 300-day average. As of Oct 3, 2026.
Follow Bio Green Med Solution in your weekly email
Every Wednesday you see whether Bio Green Med Solution is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc.
Show more
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Stock analysis
Bio Green Med Solution, Inc. (BGMS) currently trades at $0.9900, while our model-based Fair Value estimate is $0.6290, 36.5% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: $0.4165 (bear) to $0.7905 (bull), the price of $0.9900 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Industrials sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Bio Green Med Solution, Inc. reported revenue of $747K in FY2025 versus $0 in FY2021. Reported net income was −$3.0M in FY2025.
Key figures
Market cap $5.5M · P/E ratio 0.1 · P/S ratio 3.13 · EPS (TTM) $−4.99 · Dividend yield 1.0% · Net margin −118% · Return on equity 34.4% · Return on assets (EBIT) −167%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).
What moves the price
The share trades about 83% below its 52-week high and 65% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −19% fair-value upside, at −36%, BGMS screens richer than that median.
Fair Value models
Bear $0.4165Fair Value $0.6290Bull $0.7905
Price $0.9900 · Upside -36.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.16/100
Revenue growth is weak, negative or inconsistent.
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−6,365.3% (2018) → −1,128.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Bio Green Med Solution, Inc. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Building Products & Equipment · 259 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score46 · Below median
Fair Value upside−36.5% · Below median
Profitability
Return on equity (TTM)34.4% · Top 25%
Return on assets−37.0% · Bottom 25%
Net margin (TTM)−118.3% · Bottom 25%
Operating margin (TTM)−124.4% · Bottom 25%
Growth and dividend
Revenue growth710.0% · Top 25%
Dividend yield (TTM)1.0% · Below median
Valuation Multiplesvs Building Products & Equipment median · lower = cheaper
P/E (TTM)0.1× · Cheapest 25%
P/B0.81× · Cheaper than median
P/S (TTM)2.98× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 12
FUTURE (revenue growth)100· sector 19
PAST (return on equity)100· sector 23
HEALTH (low debt)0· sector 95
DIVIDEND (yield)21· sector 42
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Bio Green Med Solution, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/BGMS
Frequently asked questions
Is Bio Green Med Solution, Inc. (BGMS) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of $0.6290 versus a price of $0.9900, about −36% upside (overvalued).
What is the fair value of BGMS?
Our model-based fair value for Bio Green Med Solution, Inc. is $0.6290 (as of Oct 3, 2026), built from audited fundamentals. The current price: $0.9900.
What is the quality score of BGMS?
Bio Green Med Solution, Inc. has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bio Green Med Solution, Inc. (BGMS)?
Our model-based price target is the fair value of $0.6290 (as of Oct 3, 2026) from 1 valuation models. Cautious scenario $0.4165, optimistic scenario $0.7905. It is a calculation from audited fundamentals, not an analyst target.
What is the Bio Green Med Solution, Inc. stock forecast for 2026?
Our models put fair value at $0.6290, about −36% upside versus a price of $0.9900 (overvalued). Cautious scenario $0.4165, optimistic scenario $0.7905. The calculation is refreshed regularly with new filings.
What is the revenue of Bio Green Med Solution, Inc. (BGMS)?
Bio Green Med Solution, Inc. reported trailing-twelve-month revenue of about $1.9M (latest available figure, as of Oct 3, 2026).
Does Bio Green Med Solution, Inc. pay a dividend?
Bio Green Med Solution, Inc. currently shows a dividend yield of about 1.05% relative to its recent price (as of Oct 3, 2026).
What is the intrinsic value of Bio Green Med Solution, Inc. (BGMS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bio Green Med Solution, Inc. it is $0.6290 per share (as of Oct 3, 2026), against a price of $0.9900. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Bio Green Med Solution, Inc. stock overvalued or undervalued in 2026?
As of Oct 3, 2026, BGMS trades above its calculated fair value: price $0.9900, fair value $0.6290, a gap of about −36% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BGMS?
No. The price is what the market pays today ($0.9900); the fair value is what the company's own numbers justify ($0.6290). For Bio Green Med Solution, Inc. the two are $0.3610 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bio Green Med Solution, Inc. worth?
The market values Bio Green Med Solution, Inc. at about $5.5M (market capitalisation, as of Oct 3, 2026). Per share that is $0.9900; our models calculate a fair value of $0.6290 per share.
What do the bullish and bearish scenarios say about BGMS?
Our models span a range for Bio Green Med Solution, Inc.: cautious scenario $0.4165, base $0.6290, optimistic $0.7905 per share (as of Oct 3, 2026, price $0.9900). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BGMS?
Bio Green Med Solution, Inc. trades at a price-to-earnings ratio of 0.1 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $0.6290 is built from several models across several years. Other multiples: P/B 0.8, P/S 3.0.
How solid is the balance sheet of Bio Green Med Solution, Inc. (BGMS)?
Balance-sheet figures for Bio Green Med Solution, Inc. (as of Oct 3, 2026): return on equity 34.4%. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is BGMS from its 52-week high?
Bio Green Med Solution, Inc. trades at $0.9900, about 83% below its 52-week high of $5.95 and 65% above the low of $0.6000 (as of Oct 12, 2026). Distance from the high says nothing about value: that is what the fair value of $0.6290 is for.
Which stocks are comparable to Bio Green Med Solution, Inc.?
From the same area (Industrials) we also value Trane Technologies plc, Johnson Controls International plc, Carrier Global Corporation, Compagnie de Saint-Gobain S.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bio Green Med Solution, Inc. stock attractive at the current price?
The data as of Oct 3, 2026: price $0.9900, calculated fair value $0.6290 (−36%), Quality Score 46/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BGMS calculated?
We run Bio Green Med Solution, Inc. through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.6290, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.8 % above its aggregate fair value. Bio Green Med Solution, Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bio Green Med Solution, Inc. (BGMS)?
The closing price on Oct 12, 2026 was $0.9900. Our model-based fair value is $0.6290, about −36% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bio Green Med Solution, Inc. right now?
The price sits above even our optimistic bull case ($0.7905). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($0.4165 to $0.7905) leaves room in how you read the outcome.
Key figures of Bio Green Med Solution, Inc.
How large is the market capitalisation of Bio Green Med Solution, Inc. (BGMS)?
The market capitalisation of Bio Green Med Solution, Inc. is $5.5M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bio Green Med Solution, Inc. (BGMS)?
The price-to-sales ratio of Bio Green Med Solution, Inc. is 3.13 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bio Green Med Solution, Inc. (BGMS)?
Earnings per share at Bio Green Med Solution, Inc. are $−4.99 (price ÷ EPS = P/E 0.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Bio Green Med Solution, Inc. (BGMS)?
The dividend yield of Bio Green Med Solution, Inc. is 1.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Bio Green Med Solution, Inc. (BGMS)?
The net margin of Bio Green Med Solution, Inc. is −118% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bio Green Med Solution, Inc. (BGMS)?
The return on equity (ROE) of Bio Green Med Solution, Inc. is 34.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bio Green Med Solution, Inc. (BGMS)?
On an EBIT basis the return on assets of Bio Green Med Solution, Inc. is −167% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bio Green Med Solution, Inc. (BGMS)?
The operating margin of Bio Green Med Solution, Inc. is −124% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bio Green Med Solution, Inc. (BGMS)?
Revenue at Bio Green Med Solution, Inc. is growing +710% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Bio Green Med Solution, Inc. (BGMS) generate?
The free cash flow of Bio Green Med Solution, Inc. is −$4.8M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Bio Green Med Solution, Inc. (BGMS) hold?
Bio Green Med Solution, Inc. holds more cash than debt, $3.5M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Bio Green Med Solution, Inc. in the live analysis
One click puts Bio Green Med Solution, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
Thin data
Oct 3, 2026